glp-1 market news november 2025 Receptor Agonist Size, Trends and Share Report 2026 GLP-1 Receptor Agonist Market Size
Description
Estudios comparativos han mostrado que semaglutida y tirzepatida ofrecen mayores reducciones en HbA1c y peso en comparacin con dulaglutida
V.AsaadM.SelberJ
This is interesting given that postprandial GLP-1 levels measured in the lymph are 56 times higher relative to sampling performed in portal plasma (36)
Gastroparesia diagnosticada
While gastroparesis has multiple etiologies, in a large single-center study of 146 gastroparesis patients, 29% were found to have diabetes, 13% developed symptoms after gastric surgery and 36% were idiopathic [25]
